Kovitz Investment Group Partners’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,315	Closed	-$22.3K	–	1365
2025 Q1	$22.3K	Hold	18,315	–	–	﹤0.01%	1228
2024 Q4	$23.6K	Sell	18,315 -24,225	-57%	-$31.3K	﹤0.01%	1214
2024 Q3	$117K	Buy	+42,540	New	+$117K	﹤0.01%	972